WallStreetZenWallStreetZen

NASDAQ: TYRA
Tyra Biosciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for TYRA

Based on 2 analysts offering 12 month price targets for Tyra Biosciences Inc.
Min Forecast
$19.00-4.67%
Avg Forecast
$23.00+15.4%
Max Forecast
$27.00+35.47%

Should I buy or sell TYRA stock?

Based on 2 analysts offering ratings for Tyra Biosciences Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TYRA stock forecasts and price targets.

TYRA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-12-29
lockedlocked$00.00+00.00%2023-12-26

1 of 1

Forecast return on equity

Is TYRA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.11%

Forecast return on assets

Is TYRA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

TYRA revenue forecast

What is TYRA's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$10.6M
Avg 2 year Forecast
$77.4M
Avg 3 year Forecast
$257.1M

TYRA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TYRA$19.93$23.00+15.40%Buy
EDIT$10.53$14.50+37.70%Strong Buy
OCUL$10.75$15.00+39.53%Strong Buy
TRML$42.59$49.75+16.81%Strong Buy
FUSN$11.99$13.80+15.10%Strong Buy

Tyra Biosciences Stock Forecast FAQ

Is Tyra Biosciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: TYRA) stock is to Buy TYRA stock.

Out of 2 analysts, 0 (0%) are recommending TYRA as a Strong Buy, 2 (100%) are recommending TYRA as a Buy, 0 (0%) are recommending TYRA as a Hold, 0 (0%) are recommending TYRA as a Sell, and 0 (0%) are recommending TYRA as a Strong Sell.

If you're new to stock investing, here's how to buy Tyra Biosciences stock.

What is TYRA's revenue growth forecast for 2026-2028?

(NASDAQ: TYRA) Tyra Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 45.89%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.82%.

Tyra Biosciences's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast TYRA's revenue for 2026 to be $454,700,368, with the lowest TYRA revenue forecast at $454,700,368, and the highest TYRA revenue forecast at $454,700,368. On average, 3 Wall Street analysts forecast TYRA's revenue for 2027 to be $3,330,852,433, with the lowest TYRA revenue forecast at $2,267,904,204, and the highest TYRA revenue forecast at $4,075,510,404.

In 2028, TYRA is forecast to generate $11,071,394,205 in revenue, with the lowest revenue forecast at $8,592,372,964 and the highest revenue forecast at $16,008,380,960.

What is TYRA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: TYRA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is TYRA's Price Target?

According to 2 Wall Street analysts that have issued a 1 year TYRA price target, the average TYRA price target is $23.00, with the highest TYRA stock price forecast at $27.00 and the lowest TYRA stock price forecast at $19.00.

On average, Wall Street analysts predict that Tyra Biosciences's share price could reach $23.00 by Dec 29, 2024. The average Tyra Biosciences stock price prediction forecasts a potential upside of 15.4% from the current TYRA share price of $19.93.

What is TYRA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: TYRA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.